The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
Abstract
Recent reports have provided evidence of a link between the endogenous brain cannabinoid system and the endogenous central opioid systems. Here we report that the selective CB1 receptor antagonist SR 141716A induced behavioral and endocrine alterations associated with opiate withdrawal in morphine-dependent animals in a dose-dependent manner and that naloxone induced an opiate withdrawal syndrome in animals made cannabinoid-dependent by repeated administration of the potent cannabinoid agonist HU-210. Additionally CB1 and mu-opioid receptor mRNAs were co-localized in brain areas relevant for opiate withdrawal such as the nucleus accumbens, septum, dorsal striatum, the central amygdaloid nucleus and the habenular complex. These results suggest that CB1 cannabinoid receptors may play a role in the neuroadaptive processes associated with opiate dependence, and they lend further support for the hypothesis of a potential role of cannabinoid receptors in the neurobiological changes that culminate in drug addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Localization of cannabinoid receptor mRNA in rat brain
Matsuda, L. A., Bonner, T. I., & Lolait, S. J. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903270406 · Cited by 631
Pharmacology of Cannabinoid Receptors
Howlett, A. C. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003135 · Cited by 488
Gellert, V. F., & Holtzman, S. G. (1978) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31261-9 · Cited by 266
Welch, S. P., & Stevens, D. L. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10720-9 · Cited by 206
Vela, G., Ruiz-gayo, M., & Fuentes, J. A. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00032-2 · Cited by 118
Opioid and cannabinoid receptors
Reisine, T., & Brownstein, M. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90103-1 · Cited by 29
Research works printed but not linked: 2
- 1992, J Pharmacol Exp Ther, 262, 10
- 1978, J Pharmacol Exp Ther, 205, 536
Cited by
Involvement of the endocannabinoid system in drug addiction
Maldonado, R., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 580
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Dietrich, A., & McDaniel, W. F. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2004.011718 · Cited by 410
Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena
Lima, L. V., Abner, T. S. S., & Sluka, K. A. (2017) · The Journal of Physiology · doi:10.1113/jp273355 · Cited by 390
“Since endocannabinoids have synergistic interactions with opioids to produce antinociception (Navarro et al., 1998), one could speculate that the same interaction occurs”
BackgroundEndocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387
“As CB1 cannabinoid receptors are co-localized with A opioid receptors in the Acb (Navarro et al., 1998), it has been suggested that cannabinoids and opioids may interact at the level of these postsynaptic transduction mechanisms (Thorat and Bhargava, 1994).”
Background
Metadata
- Authors
- Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Scripps Research Institute (US)
- Venue
- NeuroReport
- Published
- 1998-10
- Volume
- 9
- Issue
- 15
- Pages
- 3397-3402
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W1988345024
- Cited by
- 152
- References
- 7
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 4
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroreport (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA04043, R01DA004043)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- CB1 receptor, opioid withdrawal, morphine dependence, SR141716A, naloxone, mu-opioid receptor, HU-210, opioid-cannabinoid interaction, neural adaptation, drug addiction, nucleus accumbens, central amygdala, habenula
- MeSH terms
- Rimonabant, Animals, Brain Chemistry, Male, Morphine Dependence, Naloxone, Narcotic Antagonists, Piperidines, Pyrazoles, Receptors, Drug, RNA, Messenger, Substance Withdrawal Syndrome, Gene Expression, Rats, Wistar, In Situ Hybridization, Receptors, Opioid, mu, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. https://app.cochat.ai/papers/10.1097/00001756-199810260-00012
- The paper
- Navarro, M., Chowen, J., Carrera, M. R. A., del Arco, I., Villanúa, M. A., Martin, Y., Roberts, A. J., Koob, G. F., & de Fonseca, F. R. (1998). CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. NeuroReport. https://doi.org/10.1097/00001756-199810260-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.